MA42480A - Préparations pharmaceutiques de dabigatran sous forme de base libre - Google Patents

Préparations pharmaceutiques de dabigatran sous forme de base libre

Info

Publication number
MA42480A
MA42480A MA042480A MA42480A MA42480A MA 42480 A MA42480 A MA 42480A MA 042480 A MA042480 A MA 042480A MA 42480 A MA42480 A MA 42480A MA 42480 A MA42480 A MA 42480A
Authority
MA
Morocco
Prior art keywords
dabigatran
free base
pharmaceutical preparations
base form
preparations
Prior art date
Application number
MA042480A
Other languages
English (en)
Inventor
Ali Türkyilmaz
Gülay Yelken
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret As filed Critical Sanovel Ilac Sanayi Ve Ticaret As
Publication of MA42480A publication Critical patent/MA42480A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
MA042480A 2015-07-20 2016-07-19 Préparations pharmaceutiques de dabigatran sous forme de base libre MA42480A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201508948 2015-07-20

Publications (1)

Publication Number Publication Date
MA42480A true MA42480A (fr) 2018-05-30

Family

ID=56561346

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042480A MA42480A (fr) 2015-07-20 2016-07-19 Préparations pharmaceutiques de dabigatran sous forme de base libre

Country Status (3)

Country Link
EP (1) EP3324946A1 (fr)
MA (1) MA42480A (fr)
WO (1) WO2017013106A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201606697A2 (tr) * 2016-05-20 2017-12-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dabi̇gatranin yeni̇ oral farmasöti̇k formülasyonlari
CN114642646A (zh) * 2020-12-19 2022-06-21 复旦大学 一种甲磺酸达比加群酯胶囊及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
EP1485094B2 (fr) 2002-03-07 2020-03-25 Boehringer Ingelheim International GmbH Forme posologique pour administration par voie orale de l'ethylester d'acide 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionique ou ses sels
DE102005020002A1 (de) 2005-04-27 2006-11-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Physiologisch verträgliche Salze von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
EP2649060B1 (fr) 2010-12-06 2017-04-05 MSN Laboratories Limited Procédé de préparation de dérivés de benzimidazole et de leurs sels
WO2014060561A1 (fr) 2012-10-19 2014-04-24 Sanovel Ilac Sanayi Ve Ticaret A.S. Formulations pharmaceutiques orales contenant du dabigatran
EP2722033A1 (fr) 2012-10-19 2014-04-23 Sanovel Ilac Sanayi ve Ticaret A.S. Compositions pharmaceutiques de Dabigatran sous forme de base libre
EP2870960A1 (fr) * 2013-11-07 2015-05-13 Siegfried AG Formes galéniques mésoporeuses pour les principes actifs faiblement solubles
CN104706609A (zh) * 2015-04-07 2015-06-17 中国药科大学 一种达比加群酯自乳化分散片及其制备方法

Also Published As

Publication number Publication date
EP3324946A1 (fr) 2018-05-30
WO2017013106A1 (fr) 2017-01-26

Similar Documents

Publication Publication Date Title
NL301217I2 (nl) tirzepatide en farmaceutisch aanvaardbare zouten daarvan
IL264730A (en) A pharmaceutical preparation containing tgfbetarii and another anti-cancer preparation
CL2018000813A1 (es) Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso.
IL262495B (en) History of isoquinolin-3-yl carboxamide and pharmaceutical preparations containing them
MA50541A (fr) Formulations pharmaceutiques
IL253123B (en) Preparations for administration through the skin and their uses
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
MA42303A (fr) Formulations pharmaceutiques
PT3412660T (pt) Derivado de sulfonamida e composição farmacêutica contendo o mesmo
MA46867A (fr) Formulations pharmaceutiques
DK3634377T3 (da) Farmaceutisk formulering
BR112017027227A2 (pt) Agente anti-câncer
MA45187A (fr) Combinaisons pharmaceutiques
MA44987A (fr) Formulations de médicaments améliorées
GB201604124D0 (en) Pharmaceutical formulation
IL248785B (en) Antecedents of ]-n5,1-dimethyl3--oxo-(3,2-dihydro-h1-pyrazol-4-yl)]-methyl-isoxazole-3-carboxamide and pharmaceutical preparations including these antecedents
MA49837A (fr) Compositions pharmaceutiques
DK3583943T3 (da) Farmaceutisk sammensætning
IL266537A (en) pharmaceutical preparation
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf
DK3280447T3 (da) Farmaceutiske formuleringer
MA41850A (fr) Nouvelles utilisations pharmaceutiques
IL263167A (en) Pharmacy preparation